1	6	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	HIF	_	_	NNP	_	_	_	_	_
2	and	_	_	CC	_	_	_	_	_
3	Vascular	_	_	NNP	_	_	_	_	_
4	Diseases	_	_	NNPS	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	vascular	_	_	JJ	_	_	_	_	_
3	pathology	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	hypoxia	_	_	NN	_	_	_	_	_
6	is	_	_	VBZ	_	_	_	_	_
7	typically	_	_	RB	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	consequence	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	altered	_	_	VBN	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	destroyed	_	_	VBN	_	_	_	_	_
14	or	_	_	CC	_	_	_	_	_
15	absent	_	_	JJ	_	_	_	_	_
16	blood	_	_	NN	_	_	_	_	_
17	vessels	_	_	NNS	_	_	_	_	_
18	leading	_	_	VBG	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	tissue	_	_	NN	_	_	_	_	_
21	ischemia	_	_	NN	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	mechanisms	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	HIF	_	_	NN	_	_	_	_	_
6	response	_	_	NN	_	_	_	_	_
7	have	_	_	VBP	_	_	_	_	_
8	therefore	_	_	RB	_	_	_	_	_
9	been	_	_	VBN	_	_	_	_	_
10	studied	_	_	VBN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	ischemic	_	_	JJ	_	_	_	_	_
13	vascular	_	_	JJ	_	_	_	_	_
14	diseases	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	such	_	_	JJ	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	myocardial	_	_	JJ	_	_	_	_	_
19	infarction	_	_	NN	_	_	_	_	_
20	(	_	_	-LRB-	_	_	_	_	_
21	consequence	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	obstruction	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	coronary	_	_	JJ	_	_	_	_	_
26	arteries	_	_	NNS	_	_	_	_	_
27	)	_	_	-RRB-	_	_	_	_	_
28	or	_	_	CC	_	_	_	_	_
29	peripheral	_	_	JJ	_	_	_	_	_
30	vascular	_	_	JJ	_	_	_	_	_
31	disease	_	_	NN	_	_	_	_	_
32	(	_	_	-LRB-	_	_	_	_	_
33	PAD	_	_	NN	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	consequence	_	_	NN	_	_	_	_	_
36	of	_	_	IN	_	_	_	_	_
37	obstruction	_	_	NN	_	_	_	_	_
38	of	_	_	IN	_	_	_	_	_
39	arteries	_	_	NNS	_	_	_	_	_
40	going	_	_	VBG	_	_	_	_	_
41	to	_	_	TO	_	_	_	_	_
42	the	_	_	DT	_	_	_	_	_
43	limbs	_	_	NNS	_	_	_	_	_
44	)	_	_	-RRB-	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_


1	Besides	_	_	IN	_	_	_	_	_
2	tissue	_	_	NN	_	_	_	_	_
3	ischemia	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	mechanisms	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	hypoxia	_	_	NN	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	ischemia	_	_	NN	_	_	_	_	_
10	can	_	_	MD	_	_	_	_	_
11	occur	_	_	VB	_	_	_	_	_
12	within	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	vascular	_	_	JJ	_	_	_	_	_
15	wall	_	_	NN	_	_	_	_	_
16	itself	_	_	PRP	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	with	_	_	IN	_	_	_	_	_
19	implications	_	_	NNS	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	diseases	_	_	NNS	_	_	_	_	_
22	such	_	_	JJ	_	_	_	_	_
23	as	_	_	IN	_	_	_	_	_
24	atherosclerosis	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	arterial	_	_	JJ	_	_	_	_	_
27	aneurysm	_	_	NN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	chronic	_	_	JJ	_	_	_	_	_
30	venous	_	_	JJ	_	_	_	_	_
31	insufficiency	_	_	NN	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	thromboembolism	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	There	_	_	EX	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	growing	_	_	VBG	_	_	_	_	_
4	evidence	_	_	NN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	HIF	_	_	NNP	_	_	_	_	_
8	pathway	_	_	NN	_	_	_	_	_
9	is	_	_	VBZ	_	_	_	_	_
10	implicated	_	_	VBN	_	_	_	_	_
11	—	_	_	:	_	_	_	_	_
12	for	_	_	IN	_	_	_	_	_
13	better	_	_	JJR	_	_	_	_	_
14	or	_	_	CC	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	worse	_	_	JJR	_	_	_	_	_
17	—	_	_	:	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	response	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	vascular	_	_	JJ	_	_	_	_	_
24	wall	_	_	NN	_	_	_	_	_
25	to	_	_	TO	_	_	_	_	_
26	inadequate	_	_	JJ	_	_	_	_	_
27	oxygenation	_	_	NN	_	_	_	_	_
28	and/or	_	_	NN	_	_	_	_	_
29	increased	_	_	VBN	_	_	_	_	_
30	cellular	_	_	JJ	_	_	_	_	_
31	oxygen	_	_	NN	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	a	_	_	DT	_	_	_	_	_
34	demand	_	_	NN	_	_	_	_	_
35	secondary	_	_	JJ	_	_	_	_	_
36	to	_	_	TO	_	_	_	_	_
37	various	_	_	JJ	_	_	_	_	_
38	stresses	_	_	NNS	_	_	_	_	_
39	or	_	_	CC	_	_	_	_	_
40	injuries	_	_	NNS	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	6.1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	HIF	_	_	NNP	_	_	_	_	_
2	and	_	_	CC	_	_	_	_	_
3	Atherosclerosis	_	_	NNP	_	_	_	_	_


1	Atherosclerosis	_	_	NN	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	a	_	_	DT	_	_	_	_	_
4	condition	_	_	NN	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	which	_	_	WDT	_	_	_	_	_
7	fatty	_	_	JJ	_	_	_	_	_
8	deposits	_	_	NNS	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	plaques	_	_	NNS	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	develop	_	_	VBP	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	arterial	_	_	JJ	_	_	_	_	_
16	wall	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	leading	_	_	VBG	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	stenosis	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	ultimately	_	_	RB	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	thrombosis	_	_	NN	_	_	_	_	_
25	of	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	vessel	_	_	NN	_	_	_	_	_
28	.	_	_	.	_	_	_	_	_


1	Atherosclerotic	_	_	JJ	_	_	_	_	_
2	plaques	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	mainly	_	_	RB	_	_	_	_	_
5	composed	_	_	VBN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	cholesterol	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	other	_	_	JJ	_	_	_	_	_
10	lipids	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	calcium	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	fibrin	_	_	NN	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	inflammatory	_	_	JJ	_	_	_	_	_
17	cells	_	_	NNS	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	Oxygen	_	_	NN	_	_	_	_	_
2	diffusion	_	_	NN	_	_	_	_	_
3	through	_	_	IN	_	_	_	_	_
4	space-occupying	_	_	JJ	_	_	_	_	_
5	atherosclerotic	_	_	JJ	_	_	_	_	_
6	plaques	_	_	NNS	_	_	_	_	_
7	could	_	_	MD	_	_	_	_	_
8	be	_	_	VB	_	_	_	_	_
9	limited	_	_	VBN	_	_	_	_	_
10	due	_	_	JJ	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	wall	_	_	NN	_	_	_	_	_
13	thickening	_	_	NN	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	Hypoxia	_	_	NN	_	_	_	_	_
2	could	_	_	MD	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	originate	_	_	VB	_	_	_	_	_
5	from	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	high	_	_	JJ	_	_	_	_	_
8	oxygen	_	_	NN	_	_	_	_	_
9	demand	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	metabolically	_	_	RB	_	_	_	_	_
12	active	_	_	JJ	_	_	_	_	_
13	inflammatory	_	_	JJ	_	_	_	_	_
14	cells	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	such	_	_	JJ	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	macrophage	_	_	NN	_	_	_	_	_
19	foam	_	_	NN	_	_	_	_	_
20	cells	_	_	NNS	_	_	_	_	_
21	that	_	_	WDT	_	_	_	_	_
22	play	_	_	VBP	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	pivotal	_	_	JJ	_	_	_	_	_
25	role	_	_	NN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	this	_	_	DT	_	_	_	_	_
28	disease	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Detection	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	HIF-1α	_	_	NN	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	activation	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	its	_	_	PRP$	_	_	_	_	_
8	target	_	_	NN	_	_	_	_	_
9	genes	_	_	NNS	_	_	_	_	_
10	occurs	_	_	VBZ	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	atherosclerotic	_	_	JJ	_	_	_	_	_
13	plaques	_	_	NNS	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_
15	During	_	_	IN	_	_	_	_	_
16	atherogenesis	_	_	NN	_	_	_	_	_
17	(	_	_	-LRB-	_	_	_	_	_
18	plaque	_	_	NN	_	_	_	_	_
19	build-up	_	_	NN	_	_	_	_	_
20	)	_	_	-RRB-	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	hypoxia	_	_	NN	_	_	_	_	_
23	increases	_	_	VBZ	_	_	_	_	_
24	angiogenesis	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	releases	_	_	VBZ	_	_	_	_	_
27	pro-inflammatory	_	_	JJ	_	_	_	_	_
28	mediators	_	_	NNS	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	activates	_	_	VBZ	_	_	_	_	_
31	MMPs	_	_	NNS	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	forms	_	_	VBZ	_	_	_	_	_
34	reactive	_	_	JJ	_	_	_	_	_
35	oxygen	_	_	NN	_	_	_	_	_
36	species	_	_	NNS	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	oxidizes	_	_	VBZ	_	_	_	_	_
40	low-density	_	_	JJ	_	_	_	_	_
41	lipoprotein	_	_	NN	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	Necrotic	_	_	JJ	_	_	_	_	_
2	cores	_	_	NNS	_	_	_	_	_
3	within	_	_	IN	_	_	_	_	_
4	atherosclerotic	_	_	JJ	_	_	_	_	_
5	plaques	_	_	NNS	_	_	_	_	_
6	can	_	_	MD	_	_	_	_	_
7	lead	_	_	VB	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	plaque	_	_	NN	_	_	_	_	_
10	instability	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	thromboembolic	_	_	JJ	_	_	_	_	_
13	complications	_	_	NNS	_	_	_	_	_
14	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	HIF-1α	_	_	NNP	_	_	_	_	_
3	protein	_	_	NN	_	_	_	_	_
4	is	_	_	VBZ	_	_	_	_	_
5	found	_	_	VBN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	tissue	_	_	NN	_	_	_	_	_
8	surrounding	_	_	VBG	_	_	_	_	_
9	atherosclerotic	_	_	JJ	_	_	_	_	_
10	arteries	_	_	NNS	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	inflammatory	_	_	JJ	_	_	_	_	_
13	macrophages	_	_	NNS	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	arterial	_	_	JJ	_	_	_	_	_
16	SMCs	_	_	NNS	_	_	_	_	_
17	around	_	_	IN	_	_	_	_	_
18	these	_	_	DT	_	_	_	_	_
19	necrotic	_	_	JJ	_	_	_	_	_
20	cores	_	_	NNS	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	Proangiogenic	_	_	JJ	_	_	_	_	_
2	HIF-target	_	_	NN	_	_	_	_	_
3	genes	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	such	_	_	JJ	_	_	_	_	_
6	as	_	_	IN	_	_	_	_	_
7	VEGF-A	_	_	NNP	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	are	_	_	VBP	_	_	_	_	_
10	responsible	_	_	JJ	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	intra-plaque	_	_	NN	_	_	_	_	_
13	neoangiogenesis	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	contributing	_	_	VBG	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	plaque	_	_	NN	_	_	_	_	_
18	instability	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	HIF-1	_	_	NNP	_	_	_	_	_
2	activity	_	_	NN	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	alters	_	_	VBZ	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	lipid	_	_	JJ	_	_	_	_	_
7	metabolism	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	macrophages	_	_	NNS	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	vascular	_	_	JJ	_	_	_	_	_
12	SMC	_	_	NNP	_	_	_	_	_
13	.	_	_	.	_	_	_	_	_


1	Finally	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	besides	_	_	IN	_	_	_	_	_
4	hypoxia	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	several	_	_	JJ	_	_	_	_	_
7	non-hypoxic	_	_	JJ	_	_	_	_	_
8	stimuli	_	_	NNS	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	HIF	_	_	NNP	_	_	_	_	_
11	have	_	_	VBP	_	_	_	_	_
12	also	_	_	RB	_	_	_	_	_
13	been	_	_	VBN	_	_	_	_	_
14	found	_	_	VBN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	plaques	_	_	NNS	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	plaque	_	_	NN	_	_	_	_	_
19	macrophages	_	_	NNS	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	such	_	_	JJ	_	_	_	_	_
22	as	_	_	IN	_	_	_	_	_
23	inflammation	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	ROS	_	_	NNPS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	vasoactive	_	_	JJ	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	thrombotic	_	_	JJ	_	_	_	_	_
30	factors	_	_	NNS	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	6.2	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	HIF	_	_	NNP	_	_	_	_	_
2	and	_	_	CC	_	_	_	_	_
3	NH	_	_	NNP	_	_	_	_	_
4	in	_	_	IN	_	_	_	_	_
5	Vascular	_	_	NNP	_	_	_	_	_
6	Grafts	_	_	NNP	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	role	_	_	NN	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	HIF	_	_	NNP	_	_	_	_	_
6	pathway	_	_	NN	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	development	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	NH	_	_	NNP	_	_	_	_	_
12	has	_	_	VBZ	_	_	_	_	_
13	also	_	_	RB	_	_	_	_	_
14	been	_	_	VBN	_	_	_	_	_
15	studied	_	_	VBN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	When	_	_	WRB	_	_	_	_	_
2	atherosclerotic	_	_	JJ	_	_	_	_	_
3	lesions	_	_	NNS	_	_	_	_	_
4	occupy	_	_	VBP	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	long	_	_	JJ	_	_	_	_	_
7	segment	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	artery	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	surgeons	_	_	NNS	_	_	_	_	_
13	frequently	_	_	RB	_	_	_	_	_
14	use	_	_	VBP	_	_	_	_	_
15	a	_	_	DT	_	_	_	_	_
16	graft	_	_	NN	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	bypass	_	_	VB	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	lesion	_	_	NN	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	provide	_	_	VB	_	_	_	_	_
23	blood	_	_	NN	_	_	_	_	_
24	to	_	_	TO	_	_	_	_	_
25	distal	_	_	JJ	_	_	_	_	_
26	tissues	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Either	_	_	CC	_	_	_	_	_
2	venous	_	_	JJ	_	_	_	_	_
3	or	_	_	CC	_	_	_	_	_
4	prosthetic	_	_	JJ	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	these	_	_	DT	_	_	_	_	_
7	grafts	_	_	NNS	_	_	_	_	_
8	are	_	_	VBP	_	_	_	_	_
9	prone	_	_	JJ	_	_	_	_	_
10	to	_	_	TO	_	_	_	_	_
11	NH	_	_	NNP	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	vein	_	_	NN	_	_	_	_	_
3	grafts	_	_	NNS	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	prosthetic	_	_	JJ	_	_	_	_	_
6	grafts	_	_	NNS	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	not	_	_	RB	_	_	_	_	_
9	identical	_	_	JJ	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	because	_	_	IN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	different	_	_	JJ	_	_	_	_	_
14	hemodynamics	_	_	NNS	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	oxygen	_	_	NN	_	_	_	_	_
17	tension	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	characteristics	_	_	NNS	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	NH	_	_	NNP	_	_	_	_	_
23	in	_	_	IN	_	_	_	_	_
24	vein	_	_	NN	_	_	_	_	_
25	grafts	_	_	NNS	_	_	_	_	_
26	are	_	_	VBP	_	_	_	_	_
27	similar	_	_	JJ	_	_	_	_	_
28	to	_	_	TO	_	_	_	_	_
29	those	_	_	DT	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	NH	_	_	NNP	_	_	_	_	_
32	that	_	_	WDT	_	_	_	_	_
33	form	_	_	VBP	_	_	_	_	_
34	in	_	_	IN	_	_	_	_	_
35	AVFs	_	_	NNP	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	animal	_	_	NN	_	_	_	_	_
5	models	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	grafts	_	_	NNS	_	_	_	_	_
8	showed	_	_	VBD	_	_	_	_	_
9	increased	_	_	VBN	_	_	_	_	_
10	hypoxia	_	_	NN	_	_	_	_	_
11	within	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	vessel	_	_	NN	_	_	_	_	_
14	wall	_	_	NN	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	regions	_	_	NNS	_	_	_	_	_
17	of	_	_	IN	_	_	_	_	_
18	neointimal	_	_	JJ	_	_	_	_	_
19	hyperplasia	_	_	NN	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	study	_	_	NN	_	_	_	_	_
3	using	_	_	VBG	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	porcine	_	_	JJ	_	_	_	_	_
6	model	_	_	NN	_	_	_	_	_
7	showed	_	_	VBD	_	_	_	_	_
8	an	_	_	DT	_	_	_	_	_
9	association	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	HIF-1α	_	_	NN	_	_	_	_	_
12	expression	_	_	NN	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	degree	_	_	NN	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	neointimal	_	_	JJ	_	_	_	_	_
18	hyperplasia	_	_	NN	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	grafts	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	suggested	_	_	VBD	_	_	_	_	_
24	that	_	_	IN	_	_	_	_	_
25	reducing	_	_	VBG	_	_	_	_	_
26	hypoxia	_	_	NN	_	_	_	_	_
27	might	_	_	MD	_	_	_	_	_
28	inhibit	_	_	VB	_	_	_	_	_
29	venous	_	_	JJ	_	_	_	_	_
30	NH	_	_	NNP	_	_	_	_	_
31	formation	_	_	NN	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	possibly	_	_	RB	_	_	_	_	_
34	by	_	_	IN	_	_	_	_	_
35	reducing	_	_	VBG	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	phenotypic	_	_	JJ	_	_	_	_	_
38	switch	_	_	NN	_	_	_	_	_
39	of	_	_	IN	_	_	_	_	_
40	fibroblasts	_	_	NNS	_	_	_	_	_
41	to	_	_	TO	_	_	_	_	_
42	myofibroblasts	_	_	NNS	_	_	_	_	_
43	.	_	_	.	_	_	_	_	_


1	Paradoxically	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	increased	_	_	VBN	_	_	_	_	_
4	activation	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	the	_	_	DT	_	_	_	_	_
7	HIF	_	_	NN	_	_	_	_	_
8	pathway	_	_	NN	_	_	_	_	_
9	may	_	_	MD	_	_	_	_	_
10	also	_	_	RB	_	_	_	_	_
11	protect	_	_	VB	_	_	_	_	_
12	against	_	_	IN	_	_	_	_	_
13	NH	_	_	NNP	_	_	_	_	_
14	formation	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_
16	Nakao	_	_	NNP	_	_	_	_	_
17	et	_	_	FW	_	_	_	_	_
18	al.	_	_	FW	_	_	_	_	_
19	studied	_	_	VBD	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	role	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	carbon	_	_	NN	_	_	_	_	_
24	monoxide	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	a	_	_	DT	_	_	_	_	_
27	physiologically	_	_	RB	_	_	_	_	_
28	important	_	_	JJ	_	_	_	_	_
29	vasodilator	_	_	NN	_	_	_	_	_
30	that	_	_	WDT	_	_	_	_	_
31	acts	_	_	VBZ	_	_	_	_	_
32	via	_	_	IN	_	_	_	_	_
33	cyclic	_	_	JJ	_	_	_	_	_
34	guanosine	_	_	NN	_	_	_	_	_
35	monophosphate	_	_	NN	_	_	_	_	_
36	,	_	_	,	_	_	_	_	_
37	in	_	_	IN	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	formation	_	_	NN	_	_	_	_	_
40	of	_	_	IN	_	_	_	_	_
41	NH	_	_	NNP	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	They	_	_	PRP	_	_	_	_	_
2	showed	_	_	VBD	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	a	_	_	DT	_	_	_	_	_
5	vein	_	_	NN	_	_	_	_	_
6	graft	_	_	NN	_	_	_	_	_
7	placed	_	_	VBD	_	_	_	_	_
8	immediately	_	_	RB	_	_	_	_	_
9	after	_	_	IN	_	_	_	_	_
10	harvest	_	_	NN	_	_	_	_	_
11	led	_	_	VBD	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	less	_	_	JJR	_	_	_	_	_
14	NH	_	_	NNP	_	_	_	_	_
15	than	_	_	IN	_	_	_	_	_
16	if	_	_	IN	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	graft	_	_	NN	_	_	_	_	_
19	was	_	_	VBD	_	_	_	_	_
20	rinsed	_	_	VBN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	lactated	_	_	VBN	_	_	_	_	_
23	Ringer	_	_	NNP	_	_	_	_	_
24	for	_	_	IN	_	_	_	_	_
25	2	_	_	CD	_	_	_	_	_
26	h	_	_	NNS	_	_	_	_	_
27	prior	_	_	JJ	_	_	_	_	_
28	to	_	_	TO	_	_	_	_	_
29	surgical	_	_	JJ	_	_	_	_	_
30	placement	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	if	_	_	IN	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	lactated	_	_	JJ	_	_	_	_	_
6	Ringer	_	_	NN	_	_	_	_	_
7	solution	_	_	NN	_	_	_	_	_
8	was	_	_	VBD	_	_	_	_	_
9	saturated	_	_	VBN	_	_	_	_	_
10	with	_	_	IN	_	_	_	_	_
11	carbon	_	_	NN	_	_	_	_	_
12	monoxide	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	it	_	_	PRP	_	_	_	_	_
15	significantly	_	_	RB	_	_	_	_	_
16	inhibited	_	_	VBD	_	_	_	_	_
17	NH	_	_	NNP	_	_	_	_	_
18	compared	_	_	VBN	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	untreated	_	_	JJ	_	_	_	_	_
22	control	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	effects	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	carbon	_	_	NN	_	_	_	_	_
5	monoxide	_	_	NN	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	inhibiting	_	_	VBG	_	_	_	_	_
8	NH	_	_	NNP	_	_	_	_	_
9	formation	_	_	NN	_	_	_	_	_
10	seemed	_	_	VBD	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	be	_	_	VB	_	_	_	_	_
13	associated	_	_	VBN	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	increased	_	_	VBN	_	_	_	_	_
16	HIF-1α	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	VEGF	_	_	NNP	_	_	_	_	_
19	expression	_	_	NN	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	few	_	_	JJ	_	_	_	_	_
22	hours	_	_	NNS	_	_	_	_	_
23	after	_	_	IN	_	_	_	_	_
24	grafting	_	_	VBG	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	This	_	_	DT	_	_	_	_	_
2	effect	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	including	_	_	VBG	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	induction	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	VEGF	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	was	_	_	VBD	_	_	_	_	_
11	reversed	_	_	VBN	_	_	_	_	_
12	by	_	_	IN	_	_	_	_	_
13	treatment	_	_	NN	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	YC-1	_	_	NNP	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	a	_	_	DT	_	_	_	_	_
18	HIF-1α	_	_	NN	_	_	_	_	_
19	inhibitor	_	_	NN	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	supporting	_	_	VBG	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	conclusion	_	_	NN	_	_	_	_	_
24	that	_	_	IN	_	_	_	_	_
25	these	_	_	DT	_	_	_	_	_
26	effects	_	_	NNS	_	_	_	_	_
27	were	_	_	VBD	_	_	_	_	_
28	mediated	_	_	VBN	_	_	_	_	_
29	through	_	_	IN	_	_	_	_	_
30	the	_	_	DT	_	_	_	_	_
31	activation	_	_	NN	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	HIF	_	_	NNP	_	_	_	_	_
35	pathway	_	_	NN	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	apparently	_	_	RB	_	_	_	_	_
3	contradictory	_	_	JJ	_	_	_	_	_
4	studies	_	_	NNS	_	_	_	_	_
5	suggest	_	_	VBP	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	at	_	_	IN	_	_	_	_	_
9	least	_	_	JJS	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	setting	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	vein	_	_	NN	_	_	_	_	_
15	graft	_	_	NN	_	_	_	_	_
16	NH	_	_	NNP	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	transient	_	_	JJ	_	_	_	_	_
19	activation	_	_	NN	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	HIF	_	_	NN	_	_	_	_	_
23	pathway	_	_	NN	_	_	_	_	_
24	may	_	_	MD	_	_	_	_	_
25	protect	_	_	VB	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	wall	_	_	NN	_	_	_	_	_
28	from	_	_	IN	_	_	_	_	_
29	hypoxia	_	_	NN	_	_	_	_	_
30	,	_	_	,	_	_	_	_	_
31	whereas	_	_	IN	_	_	_	_	_
32	chronic	_	_	JJ	_	_	_	_	_
33	activation	_	_	NN	_	_	_	_	_
34	may	_	_	MD	_	_	_	_	_
35	maintain	_	_	VB	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	ongoing	_	_	JJ	_	_	_	_	_
38	NH	_	_	NN	_	_	_	_	_
39	process	_	_	NN	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Carbon	_	_	NN	_	_	_	_	_
2	monoxide	_	_	NN	_	_	_	_	_
3	may	_	_	MD	_	_	_	_	_
4	also	_	_	RB	_	_	_	_	_
5	display	_	_	VB	_	_	_	_	_
6	vasoconstrictor	_	_	JJ	_	_	_	_	_
7	effects	_	_	NNS	_	_	_	_	_
8	depending	_	_	VBG	_	_	_	_	_
9	on	_	_	IN	_	_	_	_	_
10	oxygen	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	metabolic	_	_	JJ	_	_	_	_	_
13	homeostasis	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	including	_	_	VBG	_	_	_	_	_
16	ROS	_	_	NN	_	_	_	_	_
17	production	_	_	NN	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	highlighting	_	_	VBG	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	important	_	_	JJ	_	_	_	_	_
22	role	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	metabolism	_	_	NN	_	_	_	_	_
25	in	_	_	IN	_	_	_	_	_
26	the	_	_	DT	_	_	_	_	_
27	vascular	_	_	JJ	_	_	_	_	_
28	wall	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_

